Indirect Comparison of the Efficacy of Melphalan-Prednisone-Bortezomib Relative to Melphalan-Prednisone-Thalidomide and Melphalan-Prednisone for the First Line Treatment of Multiple Myeloma

被引：0
|
作者：
Yeh, Yating [1 ]
Chambers, James [1 ]
Gaugris, Sabine [2 ]
Jansen, Jeroen [1 ]
机构：
[1] Mapi Values, Boston, MA USA
[2] Janssen Cilag Ltd, Market Access, High Wycombe, Bucks, England
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：825 / 825
页数：1
相关论文
共 50 条
  • [21] Melphalan and prednisone versus melphalan, prednisone and thalidomide for elderly and/or transplant ineligible patients with multiple myeloma: a meta-analysis
    P Kapoor
    S V Rajkumar
    A Dispenzieri
    M A Gertz
    M Q Lacy
    D Dingli
    J R Mikhael
    V Roy
    R A Kyle
    P R Greipp
    S Kumar
    S J Mandrekar
    Leukemia, 2011, 25 : 689 - 696
  • [22] Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance With Bortezomib-Thalidomide Compared With Bortezomib-Melphalan-Prednisone for Initial Treatment of Multiple Myeloma: Updated Follow-Up and Improved Survival
    Palumbo, Antonio
    Bringhen, Sara
    Larocca, Alessandra
    Rossi, Davide
    Di Raimondo, Francesco
    Magarotto, Valeria
    Patriarca, Francesca
    Levi, Anna
    Benevolo, Giulia
    Vincelli, Iolanda Donatella
    Grasso, Mariella
    Franceschini, Luca
    Gottardi, Daniela
    Zambello, Renato
    Montefusco, Vittorio
    Falcone, Antonietta Pia
    Omede, Paola
    Marasca, Roberto
    Morabito, Fortunato
    Mina, Roberto
    Guglielmelli, Tommasina
    Nozzoli, Chiara
    Passera, Roberto
    Gaidano, Gianluca
    Offidani, Massimo
    Ria, Roberto
    Petrucci, Maria Teresa
    Musto, Pellegrino
    Boccadoro, Mario
    Cavo, Michele
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (07) : 634 - +
  • [23] Intravenous melphalan, thalidomide and prednisone in refractory and relapsed multiple myeloma
    Palumbo, A
    Avonto, I
    Bruno, B
    Ambrosini, MT
    Bringhen, S
    Cavallo, F
    Falco, P
    Boccadoro, M
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2006, 76 (04) : 273 - 277
  • [24] Updated Follow-up and Results of Subsequent Therapy in the Phase III VISTA Trial: Bortezomib Plus Melphalan-Prednisone Versus Melphalan-Prednisone in Newly Diagnosed Multiple Myeloma
    Miguel, Jesus F. San
    Schlag, Rudolf
    Khuageva, Nuriet K.
    Dimopoulos, Meletios A.
    Shpilberg, Ofer
    Kropff, Martin H.
    Spicka, Ivan
    Petrucci, Maria Teresa
    Palumbo, Antonio
    Samoilova, Olga S.
    Dmoszynska, Anna
    Abdulkadyrov, Kudrat M.
    Schots, Rik
    Jiang, Bin
    Mateos, Maria-Victoria
    Anderson, Kenneth C.
    Esseltine, Dixie-Lee
    Liu, Kevin
    Cakana, Andrew
    van de Velde, Helgi
    Richardson, Paul
    BLOOD, 2008, 112 (11) : 242 - 242
  • [25] Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: a randomised trial
    Mateos, Maria-Victoria
    Oriol, Albert
    Martinez-Lopez, Joaquin
    Gutierrez, Norma
    Teruel, Ana-Isabel
    de Paz, Raquel
    Garcia-Larana, Jose
    Bengoechea, Enrique
    Martin, Alejandro
    Diaz Mediavilla, Joaquin
    Palomera, Luis
    de Arriba, Felipe
    Gonzalez, Yolanda
    Hernandez, Jose-Mariano
    Sureda, Ana
    Bello, Jose-Luis
    Bargay, Joan
    Penalver, Francisco-Javier
    Ribera, Jose-Maria
    Martin-Mateos, Maria-Luisa
    Garcia-Sanz, Ramon
    Cibeira, Maria-Teresa
    Martin Ramos, Maria-Luisa
    Vidriales, Maria-Belen
    Paiva, Bruno
    Montalban, Maria-Angeles
    Lahuerta, Juan-Jose
    Blade, Joan
    San Miguel, Jesus-Fernando
    LANCET ONCOLOGY, 2010, 11 (10): : 934 - 941
  • [26] MMY-3002: A phase 3 study comparing bortezomib-melphalan-prednisone (VMP) with melphalan-prednisone (MP) in newly diagnosed multiple myeloma.
    San Miguel, J. F.
    Schlag, R.
    Khuageya, N.
    Shpilberg, O.
    Dimopoulos, M.
    Kropff, M.
    Spicka, L.
    Petrucci, M.
    Sarrioilova, O.
    Dmoszynska, A.
    Abdulkadyrov, K.
    Schots, R.
    Jiang, B.
    Palumbo, A.
    Mateos, M.
    Liu, K.
    Cakana, A.
    Van de Velde, H.
    Richardson, P.
    BLOOD, 2007, 110 (11) : 31A - 31A
  • [27] Persistent Overall Survival Benefit and No Increased Risk of Second Malignancies With Bortezomib-Melphalan-Prednisone Versus Melphalan-Prednisone in Patients With Previously Untreated Multiple Myeloma
    San Miguel, Jesus F.
    Schlag, Rudolf
    Khuageva, Nuriet K.
    Dimopoulos, Meletios A.
    Shpilberg, Ofer
    Kropff, Martin
    Spicka, Ivan
    Petrucci, Maria Teresa
    Palumbo, Antonio
    Samoilova, Olga S.
    Dmoszynska, Anna
    Abdulkadyrov, Kudrat M.
    Delforge, Michel
    Jiang, Bin
    Mateos, Maria-Victoria
    Anderson, Kenneth C.
    Esseltine, Dixie-Lee
    Liu, Kevin
    Deraedt, William
    Cakana, Andrew
    van de Velde, Helgi
    Richardson, Paul G.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04) : 448 - 455
  • [28] Bortezomib, Melphalan, Prednisone and Thalidomide (VMPT) Followed by Maintenance with Bortezomib and Thalidomide for Initial Treatment of Elderly Multiple Myeloma Patients
    Palumbo, Antonio
    Bringhen, Sara
    Rossi, Davide
    Ria, Roberto
    Offidani, Massimo
    Patriarca, Francesca
    Nozzoli, Chiara
    Levi, Anna
    Guglielmelli, Tommasina
    Benevolo, Giulia
    Callea, Vincenzo
    Olivero, Barbara
    Morabito, Fortunato
    Grasso, Mariella
    Marasca, Roberto
    Rizzo, Manuela
    Falcone, Antonietta Pia
    Gottardi, Daniela
    Montefusco, Vittorio
    Musolino, Caterina
    Zambello, Renato
    Cangialosi, Clotilde
    Pietrantuono, Giuseppe
    Magarotto, Valeria
    Petrucci, Maria Teresa
    Musto, Pellegrino
    Ciccone, Giovannino
    Di Raimondo, Francesco
    Gaidano, Gianluca
    Boccadoro, Mario
    BLOOD, 2009, 114 (22) : 58 - 58
  • [29] Safety and efficacy of bortezomib-melphalan-prednisone-thalidomide followed by bortezomib-thalidomide maintenance (VMPT-VT) versus bortezomib-melphalan-prednisone (VMP) in untreated multiple myeloma patients with renal impairment
    Morabito, Fortunato
    Gentile, Massimo
    Mazzone, Carla
    Rossi, Davide
    Di Raimondo, Francesco
    Bringhen, Sara
    Ria, Roberto
    Offidani, Massimo
    Patriarca, Francesca
    Nozzoli, Chiara
    Petrucci, Maria Teresa
    Benevolo, Giulia
    Vincelli, Iolanda
    Guglielmelli, Tommasina
    Grasso, Mariella
    Marasca, Roberto
    Baldini, Luca
    Montefusco, Vittorio
    Musto, Pellegrino
    Cascavilla, Nicola
    Majolino, Ignazio
    Musolino, Caterina
    Cavo, Michele
    Boccadoro, Mario
    Palumbo, Antonio
    BLOOD, 2011, 118 (22) : 5759 - 5766
  • [30] Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case-matched study
    Morabito, Fortunato
    Bringhen, Sara
    Larocca, Alessandra
    Wijermans, Pierre
    Victoria Mateos, Maria
    Gimsing, Peter
    Mazzone, Carla
    Gottardi, Daniela
    Omede, Paola
    Zweegman, Sonja
    Jose Lahuerta, Juan
    Zambello, Renato
    Musto, Pellegrino
    Magarotto, Valeria
    Schaafsma, Martijn
    Oriol, Albert
    Juliusson, Gunnar
    Cerrato, Chiara
    Catalano, Lucio
    Gentile, Massimo
    Isabel Turel, Ana
    Liberati, Anna Marina
    Cavalli, Maide
    Rossi, Davide
    Passera, Roberto
    Rosso, Stefano
    Beksac, Meral
    Cavo, Michele
    Waage, Anders
    San Miguel, Jesus
    Boccadoro, Mario
    Sonneveld, Pieter
    Palumbo, Antonio
    Offidani, Massimo
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (04) : 355 - 362
12345